Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers (Q83802452)
Jump to navigation
Jump to search
scientific article published on 03 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers |
scientific article published on 03 April 2012 |
Statements
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers (English)
S Rottey
B Sautois
J Kerger
L A D'Hondt
V Verschaeve
J-L Canon
C Dopchie
J M Vandenbulcke
N Whenham
J C Goeminne
M Clausse
D Verhoeven
P Glorieux
S Branders
P Dupont
J Schoonjans
O Feron